Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Market Cap
$819.78M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$784.88M
Interest Coverage Ratio
N/A
TTM Avg
85.72x
3Y Avg
85.72x
5Y Avg
85.72x
Market Cap
$789.11M
Interest Coverage Ratio
1.76x
TTM Avg
1.92x
3Y Avg
1.86x
5Y Avg
1.93x
Market Cap
$834.78M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$841.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apnimed, Inc. (APMD) | $807.22M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $805.85M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $804.28M | -1.44x | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $819.78M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $784.88M | N/A | 85.72x | 85.72x | 85.72x |
| AdaptHealth Corp. (AHCO)vs › | $789.11M | 1.76x | 1.92x | 1.86x | 1.93x |
| Alumis Inc. (ALMS)vs › | $825.76M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $834.78M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $841.42M | N/A | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $764.02M | -5.87x | 6.84x | 6.84x | 3.53x |
Interest Coverage
N/A
Debt/Equity
N/A
Current Ratio
N/A
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
